Submitted by dcc on Tue, 2022-01-18 13:05 Study Title: A Phase 1/2 Trial of CBL0137 (NSC# 825802, IND# TBD) in Patients with Relapsed or Refractory Solid Tumors including CNS Tumors and LymphomaCIRB: Pediatric CIRBLead Group: PEP-CTNStatus: ActiveReview Status: Available to Open
